Abstract

Phospholipase C-beta 3 (PLC beta 3) is an important effector enzyme in G protein-coupled signaling pathways. Activation of PLC beta 3 by G alpha and G beta gamma subunits has been fairly well characterized, but little is known about other protein interactions that may also regulate PLC beta 3 function. A yeast two-hybrid screen of a mouse brain cDNA library with the amino terminus of PLC beta 3 has yielded potential PLC beta 3 interacting proteins including calmodulin (CaM). Physical interaction between CaM and PLC beta 3 is supported by a positive secondary screen in yeast and the identification of a CaM binding site in the amino terminus of PLC beta 3. Co-precipitation of in vitro translated and transcribed amino- and carboxyl-terminal PLC beta 3 revealed CaM binding at a putative amino-terminal binding site. Direct physical interaction of PLC beta 3 and PLC beta 1 isoforms with CaM is supported by pull-down of both isoenzymes with CaM-Sepharose beads from 1321N1 cell lysates. CaM inhibitors reduced M1-muscarinic receptor stimulation of inositol phospholipid hydrolysis in 1321N1 astrocytoma cells consistent with a physiologic role for CaM in modulation of PLC beta activity. There was no effect of CaM kinase II inhibitors, KN-93 and KN-62, on M1-muscarinic receptor stimulation of inositol phosphate hydrolysis, consistent with a direct interaction between PLC beta isoforms and CaM.

Highlights

  • Phospholipase C-␤3 (PLC␤3) is supported by a positive secondary screen in yeast and the identification of a CaM binding site in the amino terminus of PLC␤3

  • The Calmodulin Binding Site—Binding site search and analysis site The Calmodulin Target Database2 was used for computer analysis of the PLC␤3 protein sequence

  • Three putative calmodulin-binding sites were identified in the full-length PLC␤3 protein sequence by hydropathy, ␣-helical propensity, residue weight, residue charge, hydrophobic residue content, helical class, and occurrence of key residues

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—KN-62, KN-93, KN-92, W-13, and fluphenazine were obtained from Calbiochem (San Diego, CA). Positive clones in the pACT2 vector were co-transformed into the S. cerevisiae strain PL3␣ along with pBL1 (a histidine-selectable yeast expression plasmid) containing the PH-EF-PLC␤3 fragment subcloned in-frame with the estrogen receptor DNA-binding domain. Anti-PLC␤ isozyme-selective polyclonal antibodies were added to soluble (cytosol) and membrane extract fractions at a 1:200 dilution and incubated at 4 °C overnight with continuous inversion. For preparation of cell lysates for CaM-Sepharose 4B binding assay, 1321N1 cells were plated at 3 ϫ 106 cells/10-cm plate and grown for 3 days at 37 °C with 5% CO2 in DMEM ϩ 10% fetal bovine serum and antibiotics. The lysate was centrifuged at 500 ϫ g, 4 °C, for 5 min to pellet nuclei and intact cells prior to incubation with CaM-Sepharose 4B beads as described below. Mitochondrial proteins are often considered to be false positives in yeast two-hybrid screens and were not pursued further

Cytochrome c oxidase
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call